-
-
-
-
-
-
-
Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million
-
-
-
-
-
-
-
Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021
-
-
-
-
-
-
-
Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update
-
-
-
-
-
-
-
Sol-Gel Technologies Ltd. (SLGL) Reports FDA Acceptance for Filing of NDA for Epsolay for Treatment of Inflammatory Lesions of Rosacea
-
-
12,335 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All